AMRN
Price
$0.43
Change
-$0.01 (-2.27%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
357.53M
27 days until earnings call
ANAB
Price
$18.94
Change
+$0.54 (+2.93%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
564.27M
35 days until earnings call
Ad is loading...

AMRN vs ANAB

Header iconAMRN vs ANAB Comparison
Open Charts AMRN vs ANABBanner chart's image
Amarin
Price$0.43
Change-$0.01 (-2.27%)
Volume$55.13K
Capitalization357.53M
AnaptysBio
Price$18.94
Change+$0.54 (+2.93%)
Volume$7.79K
Capitalization564.27M
AMRN vs ANAB Comparison Chart
Loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRN vs. ANAB commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Hold and ANAB is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (AMRN: $0.44 vs. ANAB: $18.40)
Brand notoriety: AMRN: Notable vs. ANAB: Not notable
AMRN represents the Pharmaceuticals: Major, while ANAB is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMRN: 80% vs. ANAB: 79%
Market capitalization -- AMRN: $357.53M vs. ANAB: $564.27M
AMRN [@Pharmaceuticals: Major] is valued at $357.53M. ANAB’s [@Biotechnology] market capitalization is $564.27M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileANAB’s FA Score has 0 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • ANAB’s FA Score: 0 green, 5 red.
According to our system of comparison, ANAB is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 5 TA indicator(s) are bullish while ANAB’s TA Score has 6 bullish TA indicator(s).

  • AMRN’s TA Score: 5 bullish, 5 bearish.
  • ANAB’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ANAB is a better buy in the short-term than AMRN.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а -3.70% price change this week, while ANAB (@Biotechnology) price change was -0.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.61%. For the same industry, the average monthly price growth was -1.70%, and the average quarterly price growth was -7.05%.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

AMRN is expected to report earnings on Apr 30, 2025.

ANAB is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.61% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANAB($564M) has a higher market cap than AMRN($358M). ANAB YTD gains are higher at: 38.973 vs. AMRN (-8.866). AMRN has higher annual earnings (EBITDA): -50.7M vs. ANAB (-92.74M). ANAB has more cash in the bank: 385M vs. AMRN (321M). AMRN has less debt than ANAB: AMRN (8.74M) vs ANAB (16M). AMRN has higher revenues than ANAB: AMRN (307M) vs ANAB (91.3M).
AMRNANABAMRN / ANAB
Capitalization358M564M63%
EBITDA-50.7M-92.74M55%
Gain YTD-8.86638.973-23%
P/E Ratio67.11N/A-
Revenue307M91.3M336%
Total Cash321M385M83%
Total Debt8.74M16M55%
FUNDAMENTALS RATINGS
AMRN vs ANAB: Fundamental Ratings
AMRN
ANAB
OUTLOOK RATING
1..100
912
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
8448
P/E GROWTH RATING
1..100
10068
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANAB's Valuation (84) in the Biotechnology industry is in the same range as AMRN (87) in the Pharmaceuticals Other industry. This means that ANAB’s stock grew similarly to AMRN’s over the last 12 months.

ANAB's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that ANAB’s stock grew similarly to AMRN’s over the last 12 months.

AMRN's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as ANAB (99) in the Biotechnology industry. This means that AMRN’s stock grew similarly to ANAB’s over the last 12 months.

ANAB's Price Growth Rating (48) in the Biotechnology industry is somewhat better than the same rating for AMRN (84) in the Pharmaceuticals Other industry. This means that ANAB’s stock grew somewhat faster than AMRN’s over the last 12 months.

ANAB's P/E Growth Rating (68) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that ANAB’s stock grew similarly to AMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNANAB
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 7 days ago
71%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 24 days ago
88%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SKSZX27.71N/A
N/A
AMG GW&K Small Cap Value Z
PGKAX22.53N/A
N/A
PGIM Jennison Technology A
FSLSX50.41N/A
N/A
Fidelity Value Strategies
OPPAX88.37N/A
N/A
Invesco Global A
SCSRX17.95N/A
N/A
Allspring Common Stock R6

AMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
-1.36%
KZR - AMRN
56%
Loosely correlated
-7.58%
CNTB - AMRN
55%
Loosely correlated
+4.04%
HRTX - AMRN
44%
Loosely correlated
-4.09%
MGNX - AMRN
44%
Loosely correlated
-3.94%
ALXO - AMRN
43%
Loosely correlated
-1.77%
More

ANAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with CLRB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
-1.02%
CLRB - ANAB
45%
Loosely correlated
-7.39%
ADCT - ANAB
41%
Loosely correlated
-4.26%
HRMY - ANAB
39%
Loosely correlated
-2.32%
AMRN - ANAB
38%
Loosely correlated
-1.36%
SPRY - ANAB
35%
Loosely correlated
-0.40%
More